Shell Companies
Build Your Comparison
Side-by-side financial analysisStock Comparison
MACI vs GFAI vs BCO vs VRRM vs ARMK
Revenue, margins, valuation, and 5-year total return — side by side.
Security & Protection Services
Security & Protection Services
Information Technology Services
Specialty Business Services
MACI vs GFAI vs BCO vs VRRM vs ARMK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Shell Companies | Security & Protection Services | Security & Protection Services | Information Technology Services | Specialty Business Services |
| Market Cap | $238M | $10M | $4.20B | $709M | $14.27B |
| Revenue (TTM) | $0.00 | $72M | $5.39B | $979M | $19.41B |
| Net Income (TTM) | $5M | $-24M | $180M | $131M | $357M |
| Gross Margin | — | 15.1% | 26.1% | 97.5% | 6.4% |
| Operating Margin | — | -27.4% | 10.6% | 23.8% | 4.3% |
| Forward P/E | 42.3x | — | 11.0x | 3.8x | 24.1x |
| Total Debt | $4M | $3M | $4.93B | $38M | $5.72B |
| Cash & Equiv. | $32K | $22M | $2.27B | $65M | $639M |
MACI vs GFAI vs BCO vs VRRM vs ARMK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 24 | Jun 26 | Return |
|---|---|---|---|
| Melar Acquisition C… (MACI) | 100 | 110.2 | +10.2% |
| Guardforce AI Co., … (GFAI) | 100 | 22.6 | -77.4% |
| The Brink's Company (BCO) | 100 | 92.7 | -7.3% |
| Verra Mobility Corp… (VRRM) | 100 | 15.5 | -84.5% |
| Aramark (ARMK) | 100 | 158.4 | +58.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MACI vs GFAI vs BCO vs VRRM vs ARMK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MACI is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 0.01, Low D/E 2.3%, current ratio 0.91x
- Beta 0.01 vs GFAI's 2.87, lower leverage
Among these 5 stocks, GFAI doesn't own a clear edge in any measured category.
BCO ranks third and is worth considering specifically for income & stability and long-term compounding.
- Dividend streak 5 yrs, beta 1.13, yield 1.0%
- 278.8% 10Y total return vs ARMK's 137.6%
- Beta 1.13, yield 1.0%, current ratio 1.51x
- 1.0% yield, 5-year raise streak, vs ARMK's 0.8%, (3 stocks pay no dividend)
VRRM carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 11.4%, EPS growth 347.4%, 3Y rev CAGR 9.7%
- 11.4% revenue growth vs MACI's -65.2%
- Lower P/E (3.8x vs 24.1x)
- 13.4% margin vs GFAI's -32.9%
ARMK is the clearest fit if your priority is momentum.
- +35.8% vs VRRM's -80.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.4% revenue growth vs MACI's -65.2% | |
| Value | Lower P/E (3.8x vs 24.1x) | |
| Quality / Margins | 13.4% margin vs GFAI's -32.9% | |
| Stability / Safety | Beta 0.01 vs GFAI's 2.87, lower leverage | |
| Dividends | 1.0% yield, 5-year raise streak, vs ARMK's 0.8%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +35.8% vs VRRM's -80.8% | |
| Efficiency (ROA) | 7.7% ROA vs GFAI's -50.2%, ROIC 23.5% vs -41.6% |
MACI vs GFAI vs BCO vs VRRM vs ARMK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
MACI vs GFAI vs BCO vs VRRM vs ARMK — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
VRRM leads in 2 of 6 categories
ARMK leads 1 • BCO leads 1 • MACI leads 0 • GFAI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
VRRM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ARMK and MACI operate at a comparable scale, with $19.4B and $0 in trailing revenue. VRRM is the more profitable business, keeping 13.4% of every revenue dollar as net income compared to GFAI's -32.9%. On growth, ARMK holds the edge at +14.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $72M | $5.4B | $979M | $19.4B |
| EBITDAEarnings before interest/tax | $4M | -$12M | $870M | $351M | $1.3B |
| Net IncomeAfter-tax profit | $5M | -$24M | $180M | $131M | $357M |
| Free Cash FlowCash after capex | -$681,989 | -$6M | $544M | $104M | $639M |
| Gross MarginGross profit ÷ Revenue | — | +15.1% | +26.1% | +97.5% | +6.4% |
| Operating MarginEBIT ÷ Revenue | — | -27.4% | +10.6% | +23.8% | +4.3% |
| Net MarginNet income ÷ Revenue | — | -32.9% | +3.3% | +13.4% | +1.8% |
| FCF MarginFCF ÷ Revenue | — | -8.8% | +10.1% | +10.6% | +3.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +3.6% | +10.3% | +0.1% | +14.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -45.3% | +38.9% | -35.3% | -15.0% | +65.2% |
Valuation Metrics
Evenly matched — GFAI and VRRM each lead in 3 of 6 comparable metrics.
Valuation Metrics
At 5.5x trailing earnings, VRRM trades at a 88% valuation discount to ARMK's 44.5x P/E. On an enterprise value basis, VRRM's 1.9x EV/EBITDA is more attractive than ARMK's 15.3x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $238M | $10M | $4.2B | $709M | $14.3B |
| Enterprise ValueMkt cap + debt − cash | $242M | -$10M | $6.9B | $682M | $19.4B |
| Trailing P/EPrice ÷ TTM EPS | 42.31x | -0.85x | 21.69x | 5.49x | 44.48x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 11.03x | 3.80x | 24.14x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.36x | — | — |
| EV / EBITDAEnterprise value multiple | — | — | 7.80x | 1.92x | 15.26x |
| Price / SalesMarket cap ÷ Revenue | — | 0.27x | 0.80x | 0.72x | 0.77x |
| Price / BookPrice ÷ Book value/share | 1.07x | 0.16x | 10.54x | 2.57x | 4.59x |
| Price / FCFMarket cap ÷ FCF | — | — | 9.62x | 5.19x | 31.40x |
Profitability & Efficiency
VRRM leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
BCO delivers a 45.6% return on equity — every $100 of shareholder capital generates $46 in annual profit, vs $-70 for GFAI. MACI carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to BCO's 12.10x. On the Piotroski fundamental quality scale (0–9), VRRM scores 8/9 vs MACI's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +2.9% | -69.7% | +45.6% | +39.7% | +11.1% |
| ROA (TTM)Return on assets | +2.7% | -50.2% | +2.5% | +7.7% | +2.6% |
| ROICReturn on invested capital | -0.7% | -41.6% | +14.2% | +23.5% | +7.3% |
| ROCEReturn on capital employed | -0.9% | -19.1% | +11.9% | +16.7% | +8.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 6 | 8 | 7 |
| Debt / EquityFinancial leverage | 0.02x | 0.08x | 12.10x | 0.13x | 1.81x |
| Net DebtTotal debt minus cash | $4M | -$19M | $2.7B | -$27M | $5.1B |
| Cash & Equiv.Liquid assets | $32,075 | $22M | $2.3B | $65M | $639M |
| Total DebtShort + long-term debt | $4M | $3M | $4.9B | $38M | $5.7B |
| Interest CoverageEBIT ÷ Interest expense | 5.43x | -167.24x | 4.75x | 3.13x | 2.37x |
Total Returns (Dividends Reinvested)
ARMK leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ARMK five years ago would be worth $20,664 today (with dividends reinvested), compared to $44 for GFAI. Over the past 12 months, ARMK leads with a +35.8% total return vs VRRM's -80.8%. The 3-year compound annual growth rate (CAGR) favors ARMK at 23.4% vs GFAI's -56.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +3.6% | -30.0% | -12.0% | -79.1% | +49.0% |
| 1-Year ReturnPast 12 months | +5.5% | -59.2% | +21.8% | -80.8% | +35.8% |
| 3-Year ReturnCumulative with dividends | +10.4% | -92.0% | +45.9% | -75.4% | +87.7% |
| 5-Year ReturnCumulative with dividends | +10.4% | -99.6% | +39.2% | -68.1% | +106.6% |
| 10-Year ReturnCumulative with dividends | +10.4% | -99.6% | +278.8% | -53.3% | +137.6% |
| CAGR (3Y)Annualised 3-year return | +3.4% | -56.9% | +13.4% | -37.3% | +23.4% |
Risk & Volatility
Evenly matched — MACI and ARMK each lead in 1 of 2 comparable metrics.
Risk & Volatility
MACI is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than GFAI's 2.87 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ARMK currently trades 98.8% from its 52-week high vs VRRM's 18.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.01x | 2.87x | 1.13x | 0.43x | 0.79x |
| 52-Week HighHighest price in past year | $11.38 | $1.50 | $136.37 | $25.83 | $54.93 |
| 52-Week LowLowest price in past year | $10.43 | $0.38 | $83.35 | $3.40 | $35.07 |
| % of 52W HighCurrent price vs 52-week peak | +96.7% | +29.9% | +74.8% | +18.1% | +98.8% |
| RSI (14)Momentum oscillator 0–100 | 42.2 | 44.2 | 41.4 | 20.6 | 68.7 |
| Avg Volume (50D)Average daily shares traded | 18K | 758K | 396K | 5.7M | 2.6M |
Analyst Outlook
BCO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BCO as "Buy", VRRM as "Hold", ARMK as "Buy". Consensus price targets imply 59.9% upside for BCO (target: $163) vs 1.8% for ARMK (target: $55). For income investors, BCO offers the higher dividend yield at 0.99% vs ARMK's 0.76%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | — | $163.00 | $5.75 | $55.25 |
| # AnalystsCovering analysts | — | — | 9 | 12 | 24 |
| Dividend YieldAnnual dividend ÷ price | — | — | +1.0% | — | +0.8% |
| Dividend StreakConsecutive years of raises | — | — | 5 | 2 | 3 |
| Dividend / ShareAnnual DPS | — | — | $1.00 | — | $0.41 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +5.0% | 0.0% | +1.0% |
VRRM leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ARMK leads in 1 (Total Returns). 2 tied.
MACI vs GFAI vs BCO vs VRRM vs ARMK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MACI or GFAI or BCO or VRRM or ARMK a better buy right now?
For growth investors, Verra Mobility Corporation (VRRM) is the stronger pick with 11.
4% revenue growth year-over-year, versus 0. 2% for Guardforce AI Co. , Limited (GFAI). Verra Mobility Corporation (VRRM) offers the better valuation at 5. 5x trailing P/E (3. 8x forward), making it the more compelling value choice. Analysts rate The Brink's Company (BCO) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MACI or GFAI or BCO or VRRM or ARMK?
On trailing P/E, Verra Mobility Corporation (VRRM) is the cheapest at 5.
5x versus Aramark at 44. 5x. On forward P/E, Verra Mobility Corporation is actually cheaper at 3. 8x.
03Which is the better long-term investment — MACI or GFAI or BCO or VRRM or ARMK?
Over the past 5 years, Aramark (ARMK) delivered a total return of +106.
6%, compared to -99. 6% for Guardforce AI Co. , Limited (GFAI). Over 10 years, the gap is even starker: BCO returned +278. 8% versus GFAI's -99. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MACI or GFAI or BCO or VRRM or ARMK?
By beta (market sensitivity over 5 years), Melar Acquisition Corp.
I (MACI) is the lower-risk stock at 0. 01β versus Guardforce AI Co. , Limited's 2. 87β — meaning GFAI is approximately 21037% more volatile than MACI relative to the S&P 500. On balance sheet safety, Melar Acquisition Corp. I (MACI) carries a lower debt/equity ratio of 2% versus 12% for The Brink's Company — giving it more financial flexibility in a downturn.
05Which is growing faster — MACI or GFAI or BCO or VRRM or ARMK?
By revenue growth (latest reported year), Verra Mobility Corporation (VRRM) is pulling ahead at 11.
4% versus 0. 2% for Guardforce AI Co. , Limited (GFAI). On earnings-per-share growth, the picture is similar: Verra Mobility Corporation grew EPS 347. 4% year-over-year, compared to 23. 2% for Aramark. Over a 3-year CAGR, ARMK leads at 10. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MACI or GFAI or BCO or VRRM or ARMK?
Verra Mobility Corporation (VRRM) is the more profitable company, earning 14.
0% net margin versus -16. 1% for Guardforce AI Co. , Limited — meaning it keeps 14. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VRRM leads at 24. 4% versus -18. 5% for GFAI. At the gross margin level — before operating expenses — VRRM leads at 96. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MACI or GFAI or BCO or VRRM or ARMK more undervalued right now?
On forward earnings alone, Verra Mobility Corporation (VRRM) trades at 3.
8x forward P/E versus 24. 1x for Aramark — 20. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BCO: 59. 9% to $163. 00.
08Which pays a better dividend — MACI or GFAI or BCO or VRRM or ARMK?
In this comparison, BCO (1.
0% yield), ARMK (0. 8% yield) pay a dividend. MACI, GFAI, VRRM do not pay a meaningful dividend and should not be held primarily for income.
09Is MACI or GFAI or BCO or VRRM or ARMK better for a retirement portfolio?
For long-horizon retirement investors, Melar Acquisition Corp.
I (MACI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01)). Guardforce AI Co. , Limited (GFAI) carries a higher beta of 2. 87 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MACI: +10. 4%, GFAI: -99. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MACI and GFAI and BCO and VRRM and ARMK?
These companies operate in different sectors (MACI (Financial Services) and GFAI (Industrials) and BCO (Industrials) and VRRM (Technology) and ARMK (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MACI is a small-cap quality compounder stock; GFAI is a small-cap quality compounder stock; BCO is a small-cap quality compounder stock; VRRM is a small-cap deep-value stock; ARMK is a mid-cap quality compounder stock. BCO, ARMK pay a dividend while MACI, GFAI, VRRM do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.